tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ResMed price target raised to $305 from $283 at Baird
PremiumThe FlyResMed price target raised to $305 from $283 at Baird
12d ago
ResMed price target raised to $325 from $285 at UBS
Premium
The Fly
ResMed price target raised to $325 from $285 at UBS
12d ago
Resmed’s Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
Premium
Ratings
Resmed’s Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating
12d ago
Resmed Announces Increased Quarterly Dividend
PremiumCompany AnnouncementsResmed Announces Increased Quarterly Dividend
13d ago
ResMed reports Q4 EPS $2.55, consensus $2.48
Premium
The Fly
ResMed reports Q4 EPS $2.55, consensus $2.48
13d ago
RMD Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RMD Earnings this Week: How Will it Perform?
15d ago
ResMed upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe FlyResMed upgraded to Outperform from Sector Perform at RBC Capital
28d ago
Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed
Premium
The Fly
Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed
3M ago
Apnimed data brings competitive threat to ResMed, says RBC Capital
Premium
The Fly
Apnimed data brings competitive threat to ResMed, says RBC Capital
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100